Global VHH Antibody Drugs Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Nanobody (Nb), also known as VHH (Variable domain of heavy chain of HCAb) antibody or single-domain antibody, is a small antibody molecule. Compared with traditional antibodies, VHH has smaller molecular size, higher stability and easier engineering, and has a wide range of biomedical application potential.
The global VHH Antibody Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “VHH Antibody Drugs Industry Forecast” looks at past sales and reviews total world VHH Antibody Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected VHH Antibody Drugs sales for 2024 through 2030. With VHH Antibody Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world VHH Antibody Drugs industry.
This Insight Report provides a comprehensive analysis of the global VHH Antibody Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on VHH Antibody Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global VHH Antibody Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for VHH Antibody Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global VHH Antibody Drugs.
United States market for VHH Antibody Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for VHH Antibody Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for VHH Antibody Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key VHH Antibody Drugs players cover Janssen Pharmaceuticals, Sanofi Company(Ablynx), Alphamab Oncology, Legend Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of VHH Antibody Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global VHH Antibody Drugs market?
What factors are driving VHH Antibody Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do VHH Antibody Drugs market opportunities vary by end market size?
How does VHH Antibody Drugs break out by Type, by Application?
Nanobody (Nb), also known as VHH (Variable domain of heavy chain of HCAb) antibody or single-domain antibody, is a small antibody molecule. Compared with traditional antibodies, VHH has smaller molecular size, higher stability and easier engineering, and has a wide range of biomedical application potential.
The global VHH Antibody Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “VHH Antibody Drugs Industry Forecast” looks at past sales and reviews total world VHH Antibody Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected VHH Antibody Drugs sales for 2024 through 2030. With VHH Antibody Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world VHH Antibody Drugs industry.
This Insight Report provides a comprehensive analysis of the global VHH Antibody Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on VHH Antibody Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global VHH Antibody Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for VHH Antibody Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global VHH Antibody Drugs.
United States market for VHH Antibody Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for VHH Antibody Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for VHH Antibody Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key VHH Antibody Drugs players cover Janssen Pharmaceuticals, Sanofi Company(Ablynx), Alphamab Oncology, Legend Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of VHH Antibody Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Monovalent Nanobody
- Bivalent Nanobody
- Bispecific Nanobody
- Others
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Janssen Pharmaceuticals
- Sanofi Company(Ablynx)
- Alphamab Oncology
- Legend Biotech
What is the 10-year outlook for the global VHH Antibody Drugs market?
What factors are driving VHH Antibody Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do VHH Antibody Drugs market opportunities vary by end market size?
How does VHH Antibody Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global VHH Antibody Drugs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for VHH Antibody Drugs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for VHH Antibody Drugs by Country/Region, 2019, 2023 & 2030
2.2 VHH Antibody Drugs Segment by Type
2.2.1 Monovalent Nanobody
2.2.2 Bivalent Nanobody
2.2.3 Bispecific Nanobody
2.2.4 Others
2.3 VHH Antibody Drugs Sales by Type
2.3.1 Global VHH Antibody Drugs Sales Market Share by Type (2019-2024)
2.3.2 Global VHH Antibody Drugs Revenue and Market Share by Type (2019-2024)
2.3.3 Global VHH Antibody Drugs Sale Price by Type (2019-2024)
2.4 VHH Antibody Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 VHH Antibody Drugs Sales by Application
2.5.1 Global VHH Antibody Drugs Sale Market Share by Application (2019-2024)
2.5.2 Global VHH Antibody Drugs Revenue and Market Share by Application (2019-2024)
2.5.3 Global VHH Antibody Drugs Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global VHH Antibody Drugs Breakdown Data by Company
3.1.1 Global VHH Antibody Drugs Annual Sales by Company (2019-2024)
3.1.2 Global VHH Antibody Drugs Sales Market Share by Company (2019-2024)
3.2 Global VHH Antibody Drugs Annual Revenue by Company (2019-2024)
3.2.1 Global VHH Antibody Drugs Revenue by Company (2019-2024)
3.2.2 Global VHH Antibody Drugs Revenue Market Share by Company (2019-2024)
3.3 Global VHH Antibody Drugs Sale Price by Company
3.4 Key Manufacturers VHH Antibody Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers VHH Antibody Drugs Product Location Distribution
3.4.2 Players VHH Antibody Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VHH ANTIBODY DRUGS BY GEOGRAPHIC REGION
4.1 World Historic VHH Antibody Drugs Market Size by Geographic Region (2019-2024)
4.1.1 Global VHH Antibody Drugs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global VHH Antibody Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic VHH Antibody Drugs Market Size by Country/Region (2019-2024)
4.2.1 Global VHH Antibody Drugs Annual Sales by Country/Region (2019-2024)
4.2.2 Global VHH Antibody Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas VHH Antibody Drugs Sales Growth
4.4 APAC VHH Antibody Drugs Sales Growth
4.5 Europe VHH Antibody Drugs Sales Growth
4.6 Middle East & Africa VHH Antibody Drugs Sales Growth
5 AMERICAS
5.1 Americas VHH Antibody Drugs Sales by Country
5.1.1 Americas VHH Antibody Drugs Sales by Country (2019-2024)
5.1.2 Americas VHH Antibody Drugs Revenue by Country (2019-2024)
5.2 Americas VHH Antibody Drugs Sales by Type (2019-2024)
5.3 Americas VHH Antibody Drugs Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC VHH Antibody Drugs Sales by Region
6.1.1 APAC VHH Antibody Drugs Sales by Region (2019-2024)
6.1.2 APAC VHH Antibody Drugs Revenue by Region (2019-2024)
6.2 APAC VHH Antibody Drugs Sales by Type (2019-2024)
6.3 APAC VHH Antibody Drugs Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe VHH Antibody Drugs by Country
7.1.1 Europe VHH Antibody Drugs Sales by Country (2019-2024)
7.1.2 Europe VHH Antibody Drugs Revenue by Country (2019-2024)
7.2 Europe VHH Antibody Drugs Sales by Type (2019-2024)
7.3 Europe VHH Antibody Drugs Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa VHH Antibody Drugs by Country
8.1.1 Middle East & Africa VHH Antibody Drugs Sales by Country (2019-2024)
8.1.2 Middle East & Africa VHH Antibody Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa VHH Antibody Drugs Sales by Type (2019-2024)
8.3 Middle East & Africa VHH Antibody Drugs Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of VHH Antibody Drugs
10.3 Manufacturing Process Analysis of VHH Antibody Drugs
10.4 Industry Chain Structure of VHH Antibody Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 VHH Antibody Drugs Distributors
11.3 VHH Antibody Drugs Customer
12 WORLD FORECAST REVIEW FOR VHH ANTIBODY DRUGS BY GEOGRAPHIC REGION
12.1 Global VHH Antibody Drugs Market Size Forecast by Region
12.1.1 Global VHH Antibody Drugs Forecast by Region (2025-2030)
12.1.2 Global VHH Antibody Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global VHH Antibody Drugs Forecast by Type (2025-2030)
12.7 Global VHH Antibody Drugs Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Janssen Pharmaceuticals
13.1.1 Janssen Pharmaceuticals Company Information
13.1.2 Janssen Pharmaceuticals VHH Antibody Drugs Product Portfolios and Specifications
13.1.3 Janssen Pharmaceuticals VHH Antibody Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Janssen Pharmaceuticals Main Business Overview
13.1.5 Janssen Pharmaceuticals Latest Developments
13.2 Sanofi Company(Ablynx)
13.2.1 Sanofi Company(Ablynx) Company Information
13.2.2 Sanofi Company(Ablynx) VHH Antibody Drugs Product Portfolios and Specifications
13.2.3 Sanofi Company(Ablynx) VHH Antibody Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sanofi Company(Ablynx) Main Business Overview
13.2.5 Sanofi Company(Ablynx) Latest Developments
13.3 Alphamab Oncology
13.3.1 Alphamab Oncology Company Information
13.3.2 Alphamab Oncology VHH Antibody Drugs Product Portfolios and Specifications
13.3.3 Alphamab Oncology VHH Antibody Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Alphamab Oncology Main Business Overview
13.3.5 Alphamab Oncology Latest Developments
13.4 Legend Biotech
13.4.1 Legend Biotech Company Information
13.4.2 Legend Biotech VHH Antibody Drugs Product Portfolios and Specifications
13.4.3 Legend Biotech VHH Antibody Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Legend Biotech Main Business Overview
13.4.5 Legend Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global VHH Antibody Drugs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for VHH Antibody Drugs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for VHH Antibody Drugs by Country/Region, 2019, 2023 & 2030
2.2 VHH Antibody Drugs Segment by Type
2.2.1 Monovalent Nanobody
2.2.2 Bivalent Nanobody
2.2.3 Bispecific Nanobody
2.2.4 Others
2.3 VHH Antibody Drugs Sales by Type
2.3.1 Global VHH Antibody Drugs Sales Market Share by Type (2019-2024)
2.3.2 Global VHH Antibody Drugs Revenue and Market Share by Type (2019-2024)
2.3.3 Global VHH Antibody Drugs Sale Price by Type (2019-2024)
2.4 VHH Antibody Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 VHH Antibody Drugs Sales by Application
2.5.1 Global VHH Antibody Drugs Sale Market Share by Application (2019-2024)
2.5.2 Global VHH Antibody Drugs Revenue and Market Share by Application (2019-2024)
2.5.3 Global VHH Antibody Drugs Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global VHH Antibody Drugs Breakdown Data by Company
3.1.1 Global VHH Antibody Drugs Annual Sales by Company (2019-2024)
3.1.2 Global VHH Antibody Drugs Sales Market Share by Company (2019-2024)
3.2 Global VHH Antibody Drugs Annual Revenue by Company (2019-2024)
3.2.1 Global VHH Antibody Drugs Revenue by Company (2019-2024)
3.2.2 Global VHH Antibody Drugs Revenue Market Share by Company (2019-2024)
3.3 Global VHH Antibody Drugs Sale Price by Company
3.4 Key Manufacturers VHH Antibody Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers VHH Antibody Drugs Product Location Distribution
3.4.2 Players VHH Antibody Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VHH ANTIBODY DRUGS BY GEOGRAPHIC REGION
4.1 World Historic VHH Antibody Drugs Market Size by Geographic Region (2019-2024)
4.1.1 Global VHH Antibody Drugs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global VHH Antibody Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic VHH Antibody Drugs Market Size by Country/Region (2019-2024)
4.2.1 Global VHH Antibody Drugs Annual Sales by Country/Region (2019-2024)
4.2.2 Global VHH Antibody Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas VHH Antibody Drugs Sales Growth
4.4 APAC VHH Antibody Drugs Sales Growth
4.5 Europe VHH Antibody Drugs Sales Growth
4.6 Middle East & Africa VHH Antibody Drugs Sales Growth
5 AMERICAS
5.1 Americas VHH Antibody Drugs Sales by Country
5.1.1 Americas VHH Antibody Drugs Sales by Country (2019-2024)
5.1.2 Americas VHH Antibody Drugs Revenue by Country (2019-2024)
5.2 Americas VHH Antibody Drugs Sales by Type (2019-2024)
5.3 Americas VHH Antibody Drugs Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC VHH Antibody Drugs Sales by Region
6.1.1 APAC VHH Antibody Drugs Sales by Region (2019-2024)
6.1.2 APAC VHH Antibody Drugs Revenue by Region (2019-2024)
6.2 APAC VHH Antibody Drugs Sales by Type (2019-2024)
6.3 APAC VHH Antibody Drugs Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe VHH Antibody Drugs by Country
7.1.1 Europe VHH Antibody Drugs Sales by Country (2019-2024)
7.1.2 Europe VHH Antibody Drugs Revenue by Country (2019-2024)
7.2 Europe VHH Antibody Drugs Sales by Type (2019-2024)
7.3 Europe VHH Antibody Drugs Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa VHH Antibody Drugs by Country
8.1.1 Middle East & Africa VHH Antibody Drugs Sales by Country (2019-2024)
8.1.2 Middle East & Africa VHH Antibody Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa VHH Antibody Drugs Sales by Type (2019-2024)
8.3 Middle East & Africa VHH Antibody Drugs Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of VHH Antibody Drugs
10.3 Manufacturing Process Analysis of VHH Antibody Drugs
10.4 Industry Chain Structure of VHH Antibody Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 VHH Antibody Drugs Distributors
11.3 VHH Antibody Drugs Customer
12 WORLD FORECAST REVIEW FOR VHH ANTIBODY DRUGS BY GEOGRAPHIC REGION
12.1 Global VHH Antibody Drugs Market Size Forecast by Region
12.1.1 Global VHH Antibody Drugs Forecast by Region (2025-2030)
12.1.2 Global VHH Antibody Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global VHH Antibody Drugs Forecast by Type (2025-2030)
12.7 Global VHH Antibody Drugs Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Janssen Pharmaceuticals
13.1.1 Janssen Pharmaceuticals Company Information
13.1.2 Janssen Pharmaceuticals VHH Antibody Drugs Product Portfolios and Specifications
13.1.3 Janssen Pharmaceuticals VHH Antibody Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Janssen Pharmaceuticals Main Business Overview
13.1.5 Janssen Pharmaceuticals Latest Developments
13.2 Sanofi Company(Ablynx)
13.2.1 Sanofi Company(Ablynx) Company Information
13.2.2 Sanofi Company(Ablynx) VHH Antibody Drugs Product Portfolios and Specifications
13.2.3 Sanofi Company(Ablynx) VHH Antibody Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sanofi Company(Ablynx) Main Business Overview
13.2.5 Sanofi Company(Ablynx) Latest Developments
13.3 Alphamab Oncology
13.3.1 Alphamab Oncology Company Information
13.3.2 Alphamab Oncology VHH Antibody Drugs Product Portfolios and Specifications
13.3.3 Alphamab Oncology VHH Antibody Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Alphamab Oncology Main Business Overview
13.3.5 Alphamab Oncology Latest Developments
13.4 Legend Biotech
13.4.1 Legend Biotech Company Information
13.4.2 Legend Biotech VHH Antibody Drugs Product Portfolios and Specifications
13.4.3 Legend Biotech VHH Antibody Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Legend Biotech Main Business Overview
13.4.5 Legend Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. VHH Antibody Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. VHH Antibody Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Monovalent Nanobody
Table 4. Major Players of Bivalent Nanobody
Table 5. Major Players of Bispecific Nanobody
Table 6. Major Players of Others
Table 7. Global VHH Antibody Drugs Sales by Type (2019-2024) & (K Units)
Table 8. Global VHH Antibody Drugs Sales Market Share by Type (2019-2024)
Table 9. Global VHH Antibody Drugs Revenue by Type (2019-2024) & ($ million)
Table 10. Global VHH Antibody Drugs Revenue Market Share by Type (2019-2024)
Table 11. Global VHH Antibody Drugs Sale Price by Type (2019-2024) & (US$/Unit)
Table 12. Global VHH Antibody Drugs Sale by Application (2019-2024) & (K Units)
Table 13. Global VHH Antibody Drugs Sale Market Share by Application (2019-2024)
Table 14. Global VHH Antibody Drugs Revenue by Application (2019-2024) & ($ million)
Table 15. Global VHH Antibody Drugs Revenue Market Share by Application (2019-2024)
Table 16. Global VHH Antibody Drugs Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global VHH Antibody Drugs Sales by Company (2019-2024) & (K Units)
Table 18. Global VHH Antibody Drugs Sales Market Share by Company (2019-2024)
Table 19. Global VHH Antibody Drugs Revenue by Company (2019-2024) & ($ millions)
Table 20. Global VHH Antibody Drugs Revenue Market Share by Company (2019-2024)
Table 21. Global VHH Antibody Drugs Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers VHH Antibody Drugs Producing Area Distribution and Sales Area
Table 23. Players VHH Antibody Drugs Products Offered
Table 24. VHH Antibody Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global VHH Antibody Drugs Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global VHH Antibody Drugs Sales Market Share Geographic Region (2019-2024)
Table 29. Global VHH Antibody Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global VHH Antibody Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global VHH Antibody Drugs Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global VHH Antibody Drugs Sales Market Share by Country/Region (2019-2024)
Table 33. Global VHH Antibody Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global VHH Antibody Drugs Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas VHH Antibody Drugs Sales by Country (2019-2024) & (K Units)
Table 36. Americas VHH Antibody Drugs Sales Market Share by Country (2019-2024)
Table 37. Americas VHH Antibody Drugs Revenue by Country (2019-2024) & ($ millions)
Table 38. Americas VHH Antibody Drugs Sales by Type (2019-2024) & (K Units)
Table 39. Americas VHH Antibody Drugs Sales by Application (2019-2024) & (K Units)
Table 40. APAC VHH Antibody Drugs Sales by Region (2019-2024) & (K Units)
Table 41. APAC VHH Antibody Drugs Sales Market Share by Region (2019-2024)
Table 42. APAC VHH Antibody Drugs Revenue by Region (2019-2024) & ($ millions)
Table 43. APAC VHH Antibody Drugs Sales by Type (2019-2024) & (K Units)
Table 44. APAC VHH Antibody Drugs Sales by Application (2019-2024) & (K Units)
Table 45. Europe VHH Antibody Drugs Sales by Country (2019-2024) & (K Units)
Table 46. Europe VHH Antibody Drugs Revenue by Country (2019-2024) & ($ millions)
Table 47. Europe VHH Antibody Drugs Sales by Type (2019-2024) & (K Units)
Table 48. Europe VHH Antibody Drugs Sales by Application (2019-2024) & (K Units)
Table 49. Middle East & Africa VHH Antibody Drugs Sales by Country (2019-2024) & (K Units)
Table 50. Middle East & Africa VHH Antibody Drugs Revenue Market Share by Country (2019-2024)
Table 51. Middle East & Africa VHH Antibody Drugs Sales by Type (2019-2024) & (K Units)
Table 52. Middle East & Africa VHH Antibody Drugs Sales by Application (2019-2024) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of VHH Antibody Drugs
Table 54. Key Market Challenges & Risks of VHH Antibody Drugs
Table 55. Key Industry Trends of VHH Antibody Drugs
Table 56. VHH Antibody Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. VHH Antibody Drugs Distributors List
Table 59. VHH Antibody Drugs Customer List
Table 60. Global VHH Antibody Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 61. Global VHH Antibody Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 62. Americas VHH Antibody Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 63. Americas VHH Antibody Drugs Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 64. APAC VHH Antibody Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 65. APAC VHH Antibody Drugs Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Europe VHH Antibody Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Europe VHH Antibody Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Middle East & Africa VHH Antibody Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Middle East & Africa VHH Antibody Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. Global VHH Antibody Drugs Sales Forecast by Type (2025-2030) & (K Units)
Table 71. Global VHH Antibody Drugs Revenue Forecast by Type (2025-2030) & ($ millions)
Table 72. Global VHH Antibody Drugs Sales Forecast by Application (2025-2030) & (K Units)
Table 73. Global VHH Antibody Drugs Revenue Forecast by Application (2025-2030) & ($ millions)
Table 74. Janssen Pharmaceuticals Basic Information, VHH Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Janssen Pharmaceuticals VHH Antibody Drugs Product Portfolios and Specifications
Table 76. Janssen Pharmaceuticals VHH Antibody Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 77. Janssen Pharmaceuticals Main Business
Table 78. Janssen Pharmaceuticals Latest Developments
Table 79. Sanofi Company(Ablynx) Basic Information, VHH Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Sanofi Company(Ablynx) VHH Antibody Drugs Product Portfolios and Specifications
Table 81. Sanofi Company(Ablynx) VHH Antibody Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. Sanofi Company(Ablynx) Main Business
Table 83. Sanofi Company(Ablynx) Latest Developments
Table 84. Alphamab Oncology Basic Information, VHH Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Alphamab Oncology VHH Antibody Drugs Product Portfolios and Specifications
Table 86. Alphamab Oncology VHH Antibody Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Alphamab Oncology Main Business
Table 88. Alphamab Oncology Latest Developments
Table 89. Legend Biotech Basic Information, VHH Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Legend Biotech VHH Antibody Drugs Product Portfolios and Specifications
Table 91. Legend Biotech VHH Antibody Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Legend Biotech Main Business
Table 93. Legend Biotech Latest Developments
Table 1. VHH Antibody Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. VHH Antibody Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Monovalent Nanobody
Table 4. Major Players of Bivalent Nanobody
Table 5. Major Players of Bispecific Nanobody
Table 6. Major Players of Others
Table 7. Global VHH Antibody Drugs Sales by Type (2019-2024) & (K Units)
Table 8. Global VHH Antibody Drugs Sales Market Share by Type (2019-2024)
Table 9. Global VHH Antibody Drugs Revenue by Type (2019-2024) & ($ million)
Table 10. Global VHH Antibody Drugs Revenue Market Share by Type (2019-2024)
Table 11. Global VHH Antibody Drugs Sale Price by Type (2019-2024) & (US$/Unit)
Table 12. Global VHH Antibody Drugs Sale by Application (2019-2024) & (K Units)
Table 13. Global VHH Antibody Drugs Sale Market Share by Application (2019-2024)
Table 14. Global VHH Antibody Drugs Revenue by Application (2019-2024) & ($ million)
Table 15. Global VHH Antibody Drugs Revenue Market Share by Application (2019-2024)
Table 16. Global VHH Antibody Drugs Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global VHH Antibody Drugs Sales by Company (2019-2024) & (K Units)
Table 18. Global VHH Antibody Drugs Sales Market Share by Company (2019-2024)
Table 19. Global VHH Antibody Drugs Revenue by Company (2019-2024) & ($ millions)
Table 20. Global VHH Antibody Drugs Revenue Market Share by Company (2019-2024)
Table 21. Global VHH Antibody Drugs Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers VHH Antibody Drugs Producing Area Distribution and Sales Area
Table 23. Players VHH Antibody Drugs Products Offered
Table 24. VHH Antibody Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global VHH Antibody Drugs Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global VHH Antibody Drugs Sales Market Share Geographic Region (2019-2024)
Table 29. Global VHH Antibody Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global VHH Antibody Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global VHH Antibody Drugs Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global VHH Antibody Drugs Sales Market Share by Country/Region (2019-2024)
Table 33. Global VHH Antibody Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global VHH Antibody Drugs Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas VHH Antibody Drugs Sales by Country (2019-2024) & (K Units)
Table 36. Americas VHH Antibody Drugs Sales Market Share by Country (2019-2024)
Table 37. Americas VHH Antibody Drugs Revenue by Country (2019-2024) & ($ millions)
Table 38. Americas VHH Antibody Drugs Sales by Type (2019-2024) & (K Units)
Table 39. Americas VHH Antibody Drugs Sales by Application (2019-2024) & (K Units)
Table 40. APAC VHH Antibody Drugs Sales by Region (2019-2024) & (K Units)
Table 41. APAC VHH Antibody Drugs Sales Market Share by Region (2019-2024)
Table 42. APAC VHH Antibody Drugs Revenue by Region (2019-2024) & ($ millions)
Table 43. APAC VHH Antibody Drugs Sales by Type (2019-2024) & (K Units)
Table 44. APAC VHH Antibody Drugs Sales by Application (2019-2024) & (K Units)
Table 45. Europe VHH Antibody Drugs Sales by Country (2019-2024) & (K Units)
Table 46. Europe VHH Antibody Drugs Revenue by Country (2019-2024) & ($ millions)
Table 47. Europe VHH Antibody Drugs Sales by Type (2019-2024) & (K Units)
Table 48. Europe VHH Antibody Drugs Sales by Application (2019-2024) & (K Units)
Table 49. Middle East & Africa VHH Antibody Drugs Sales by Country (2019-2024) & (K Units)
Table 50. Middle East & Africa VHH Antibody Drugs Revenue Market Share by Country (2019-2024)
Table 51. Middle East & Africa VHH Antibody Drugs Sales by Type (2019-2024) & (K Units)
Table 52. Middle East & Africa VHH Antibody Drugs Sales by Application (2019-2024) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of VHH Antibody Drugs
Table 54. Key Market Challenges & Risks of VHH Antibody Drugs
Table 55. Key Industry Trends of VHH Antibody Drugs
Table 56. VHH Antibody Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. VHH Antibody Drugs Distributors List
Table 59. VHH Antibody Drugs Customer List
Table 60. Global VHH Antibody Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 61. Global VHH Antibody Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 62. Americas VHH Antibody Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 63. Americas VHH Antibody Drugs Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 64. APAC VHH Antibody Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 65. APAC VHH Antibody Drugs Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Europe VHH Antibody Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Europe VHH Antibody Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Middle East & Africa VHH Antibody Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Middle East & Africa VHH Antibody Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. Global VHH Antibody Drugs Sales Forecast by Type (2025-2030) & (K Units)
Table 71. Global VHH Antibody Drugs Revenue Forecast by Type (2025-2030) & ($ millions)
Table 72. Global VHH Antibody Drugs Sales Forecast by Application (2025-2030) & (K Units)
Table 73. Global VHH Antibody Drugs Revenue Forecast by Application (2025-2030) & ($ millions)
Table 74. Janssen Pharmaceuticals Basic Information, VHH Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Janssen Pharmaceuticals VHH Antibody Drugs Product Portfolios and Specifications
Table 76. Janssen Pharmaceuticals VHH Antibody Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 77. Janssen Pharmaceuticals Main Business
Table 78. Janssen Pharmaceuticals Latest Developments
Table 79. Sanofi Company(Ablynx) Basic Information, VHH Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Sanofi Company(Ablynx) VHH Antibody Drugs Product Portfolios and Specifications
Table 81. Sanofi Company(Ablynx) VHH Antibody Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. Sanofi Company(Ablynx) Main Business
Table 83. Sanofi Company(Ablynx) Latest Developments
Table 84. Alphamab Oncology Basic Information, VHH Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Alphamab Oncology VHH Antibody Drugs Product Portfolios and Specifications
Table 86. Alphamab Oncology VHH Antibody Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Alphamab Oncology Main Business
Table 88. Alphamab Oncology Latest Developments
Table 89. Legend Biotech Basic Information, VHH Antibody Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Legend Biotech VHH Antibody Drugs Product Portfolios and Specifications
Table 91. Legend Biotech VHH Antibody Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Legend Biotech Main Business
Table 93. Legend Biotech Latest Developments
LIST OF FIGURES
Figure 1. Picture of VHH Antibody Drugs
Figure 2. VHH Antibody Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global VHH Antibody Drugs Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global VHH Antibody Drugs Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. VHH Antibody Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. VHH Antibody Drugs Sales Market Share by Country/Region (2023)
Figure 10. VHH Antibody Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Monovalent Nanobody
Figure 12. Product Picture of Bivalent Nanobody
Figure 13. Product Picture of Bispecific Nanobody
Figure 14. Product Picture of Others
Figure 15. Global VHH Antibody Drugs Sales Market Share by Type in 2023
Figure 16. Global VHH Antibody Drugs Revenue Market Share by Type (2019-2024)
Figure 17. VHH Antibody Drugs Consumed in Hospital
Figure 18. Global VHH Antibody Drugs Market: Hospital (2019-2024) & (K Units)
Figure 19. VHH Antibody Drugs Consumed in Clinic
Figure 20. Global VHH Antibody Drugs Market: Clinic (2019-2024) & (K Units)
Figure 21. VHH Antibody Drugs Consumed in Other
Figure 22. Global VHH Antibody Drugs Market: Other (2019-2024) & (K Units)
Figure 23. Global VHH Antibody Drugs Sale Market Share by Application (2023)
Figure 24. Global VHH Antibody Drugs Revenue Market Share by Application in 2023
Figure 25. VHH Antibody Drugs Sales by Company in 2023 (K Units)
Figure 26. Global VHH Antibody Drugs Sales Market Share by Company in 2023
Figure 27. VHH Antibody Drugs Revenue by Company in 2023 ($ millions)
Figure 28. Global VHH Antibody Drugs Revenue Market Share by Company in 2023
Figure 29. Global VHH Antibody Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global VHH Antibody Drugs Revenue Market Share by Geographic Region in 2023
Figure 31. Americas VHH Antibody Drugs Sales 2019-2024 (K Units)
Figure 32. Americas VHH Antibody Drugs Revenue 2019-2024 ($ millions)
Figure 33. APAC VHH Antibody Drugs Sales 2019-2024 (K Units)
Figure 34. APAC VHH Antibody Drugs Revenue 2019-2024 ($ millions)
Figure 35. Europe VHH Antibody Drugs Sales 2019-2024 (K Units)
Figure 36. Europe VHH Antibody Drugs Revenue 2019-2024 ($ millions)
Figure 37. Middle East & Africa VHH Antibody Drugs Sales 2019-2024 (K Units)
Figure 38. Middle East & Africa VHH Antibody Drugs Revenue 2019-2024 ($ millions)
Figure 39. Americas VHH Antibody Drugs Sales Market Share by Country in 2023
Figure 40. Americas VHH Antibody Drugs Revenue Market Share by Country (2019-2024)
Figure 41. Americas VHH Antibody Drugs Sales Market Share by Type (2019-2024)
Figure 42. Americas VHH Antibody Drugs Sales Market Share by Application (2019-2024)
Figure 43. United States VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 44. Canada VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 45. Mexico VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 46. Brazil VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 47. APAC VHH Antibody Drugs Sales Market Share by Region in 2023
Figure 48. APAC VHH Antibody Drugs Revenue Market Share by Region (2019-2024)
Figure 49. APAC VHH Antibody Drugs Sales Market Share by Type (2019-2024)
Figure 50. APAC VHH Antibody Drugs Sales Market Share by Application (2019-2024)
Figure 51. China VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 52. Japan VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 53. South Korea VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 54. Southeast Asia VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 55. India VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 56. Australia VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 57. China Taiwan VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 58. Europe VHH Antibody Drugs Sales Market Share by Country in 2023
Figure 59. Europe VHH Antibody Drugs Revenue Market Share by Country (2019-2024)
Figure 60. Europe VHH Antibody Drugs Sales Market Share by Type (2019-2024)
Figure 61. Europe VHH Antibody Drugs Sales Market Share by Application (2019-2024)
Figure 62. Germany VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 63. France VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 64. UK VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 65. Italy VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 66. Russia VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 67. Middle East & Africa VHH Antibody Drugs Sales Market Share by Country (2019-2024)
Figure 68. Middle East & Africa VHH Antibody Drugs Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa VHH Antibody Drugs Sales Market Share by Application (2019-2024)
Figure 70. Egypt VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 71. South Africa VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 72. Israel VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 73. Turkey VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 74. GCC Countries VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of VHH Antibody Drugs in 2023
Figure 76. Manufacturing Process Analysis of VHH Antibody Drugs
Figure 77. Industry Chain Structure of VHH Antibody Drugs
Figure 78. Channels of Distribution
Figure 79. Global VHH Antibody Drugs Sales Market Forecast by Region (2025-2030)
Figure 80. Global VHH Antibody Drugs Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global VHH Antibody Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global VHH Antibody Drugs Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global VHH Antibody Drugs Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global VHH Antibody Drugs Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of VHH Antibody Drugs
Figure 2. VHH Antibody Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global VHH Antibody Drugs Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global VHH Antibody Drugs Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. VHH Antibody Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. VHH Antibody Drugs Sales Market Share by Country/Region (2023)
Figure 10. VHH Antibody Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Monovalent Nanobody
Figure 12. Product Picture of Bivalent Nanobody
Figure 13. Product Picture of Bispecific Nanobody
Figure 14. Product Picture of Others
Figure 15. Global VHH Antibody Drugs Sales Market Share by Type in 2023
Figure 16. Global VHH Antibody Drugs Revenue Market Share by Type (2019-2024)
Figure 17. VHH Antibody Drugs Consumed in Hospital
Figure 18. Global VHH Antibody Drugs Market: Hospital (2019-2024) & (K Units)
Figure 19. VHH Antibody Drugs Consumed in Clinic
Figure 20. Global VHH Antibody Drugs Market: Clinic (2019-2024) & (K Units)
Figure 21. VHH Antibody Drugs Consumed in Other
Figure 22. Global VHH Antibody Drugs Market: Other (2019-2024) & (K Units)
Figure 23. Global VHH Antibody Drugs Sale Market Share by Application (2023)
Figure 24. Global VHH Antibody Drugs Revenue Market Share by Application in 2023
Figure 25. VHH Antibody Drugs Sales by Company in 2023 (K Units)
Figure 26. Global VHH Antibody Drugs Sales Market Share by Company in 2023
Figure 27. VHH Antibody Drugs Revenue by Company in 2023 ($ millions)
Figure 28. Global VHH Antibody Drugs Revenue Market Share by Company in 2023
Figure 29. Global VHH Antibody Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global VHH Antibody Drugs Revenue Market Share by Geographic Region in 2023
Figure 31. Americas VHH Antibody Drugs Sales 2019-2024 (K Units)
Figure 32. Americas VHH Antibody Drugs Revenue 2019-2024 ($ millions)
Figure 33. APAC VHH Antibody Drugs Sales 2019-2024 (K Units)
Figure 34. APAC VHH Antibody Drugs Revenue 2019-2024 ($ millions)
Figure 35. Europe VHH Antibody Drugs Sales 2019-2024 (K Units)
Figure 36. Europe VHH Antibody Drugs Revenue 2019-2024 ($ millions)
Figure 37. Middle East & Africa VHH Antibody Drugs Sales 2019-2024 (K Units)
Figure 38. Middle East & Africa VHH Antibody Drugs Revenue 2019-2024 ($ millions)
Figure 39. Americas VHH Antibody Drugs Sales Market Share by Country in 2023
Figure 40. Americas VHH Antibody Drugs Revenue Market Share by Country (2019-2024)
Figure 41. Americas VHH Antibody Drugs Sales Market Share by Type (2019-2024)
Figure 42. Americas VHH Antibody Drugs Sales Market Share by Application (2019-2024)
Figure 43. United States VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 44. Canada VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 45. Mexico VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 46. Brazil VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 47. APAC VHH Antibody Drugs Sales Market Share by Region in 2023
Figure 48. APAC VHH Antibody Drugs Revenue Market Share by Region (2019-2024)
Figure 49. APAC VHH Antibody Drugs Sales Market Share by Type (2019-2024)
Figure 50. APAC VHH Antibody Drugs Sales Market Share by Application (2019-2024)
Figure 51. China VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 52. Japan VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 53. South Korea VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 54. Southeast Asia VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 55. India VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 56. Australia VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 57. China Taiwan VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 58. Europe VHH Antibody Drugs Sales Market Share by Country in 2023
Figure 59. Europe VHH Antibody Drugs Revenue Market Share by Country (2019-2024)
Figure 60. Europe VHH Antibody Drugs Sales Market Share by Type (2019-2024)
Figure 61. Europe VHH Antibody Drugs Sales Market Share by Application (2019-2024)
Figure 62. Germany VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 63. France VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 64. UK VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 65. Italy VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 66. Russia VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 67. Middle East & Africa VHH Antibody Drugs Sales Market Share by Country (2019-2024)
Figure 68. Middle East & Africa VHH Antibody Drugs Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa VHH Antibody Drugs Sales Market Share by Application (2019-2024)
Figure 70. Egypt VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 71. South Africa VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 72. Israel VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 73. Turkey VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 74. GCC Countries VHH Antibody Drugs Revenue Growth 2019-2024 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of VHH Antibody Drugs in 2023
Figure 76. Manufacturing Process Analysis of VHH Antibody Drugs
Figure 77. Industry Chain Structure of VHH Antibody Drugs
Figure 78. Channels of Distribution
Figure 79. Global VHH Antibody Drugs Sales Market Forecast by Region (2025-2030)
Figure 80. Global VHH Antibody Drugs Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global VHH Antibody Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global VHH Antibody Drugs Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global VHH Antibody Drugs Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global VHH Antibody Drugs Revenue Market Share Forecast by Application (2025-2030)
